Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01383148
Title Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
Acronym TIME
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Transgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | ISR | HUN | GBR | FRA | ESP | DEU | BEL


No variant requirements are available.